These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12356367)
1. [A review of naltrexone maintenance programs: effectiveness, predictors and profile]. Madoz-Gúrpide A; Ochoa E; Baca-García E Med Clin (Barc); 2002 Sep; 119(9):351-5. PubMed ID: 12356367 [No Abstract] [Full Text] [Related]
2. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction. Simon DL Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434 [No Abstract] [Full Text] [Related]
3. First, do no harm: naltrexone-accelerated detoxification. Gaughwin MD Med J Aust; 1999 Nov; 171(9):499. PubMed ID: 10615346 [No Abstract] [Full Text] [Related]
4. Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT. Friedmann PD; Dunn KE; Nunes EV; O'Brien CP J Subst Abuse Treat; 2018 Feb; 85():31-33. PubMed ID: 29273249 [No Abstract] [Full Text] [Related]
5. [Limited role of naltrexone in the treatment of opiate addiction]. van Brussel GH Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313 [TBL] [Abstract][Full Text] [Related]
7. [Alcohol consumption in opioid-dependence patients in treatment with naltrexone]. Ochoa Mangado E; Arias Horcajadas F Actas Esp Psiquiatr; 2000; 28(4):239-49. PubMed ID: 11116795 [TBL] [Abstract][Full Text] [Related]
8. An ethical framework for conducting research on pregnant, opioid-dependent women. McCullough LB; Chervenak FA; Coverdale JH Addiction; 2013 Feb; 108(2):248-9. PubMed ID: 23331876 [No Abstract] [Full Text] [Related]
9. Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women? Stitzer ML Addiction; 2013 Feb; 108(2):249-50. PubMed ID: 23331877 [No Abstract] [Full Text] [Related]
11. [Long-acting naltrexone--a new way out of opiate addiction?]. Stavseth LS; Kunøe N; Tanum L Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2231-2. PubMed ID: 24226324 [No Abstract] [Full Text] [Related]
12. [An interim analysis of the results of treatment program implementation with the use of injectable extended-release naltrexone for opioid addicted patients]. Agibalova TV; Nedobylskiy OV; Poplevchenkov KN; Sirotko II; Shcherban AV; Tsarev SA Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):32-34. PubMed ID: 28745668 [TBL] [Abstract][Full Text] [Related]
13. Risks associated with the inappropriate use of naltrexone in the treatment of opioid dependence. Latt NC Med J Aust; 1999 Nov; 171(9):500-1. PubMed ID: 10615348 [No Abstract] [Full Text] [Related]
14. Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Miotto K; McCann MJ; Rawson RA; Frosch D; Ling W Drug Alcohol Depend; 1997 Apr; 45(1-2):131-4. PubMed ID: 9179515 [TBL] [Abstract][Full Text] [Related]
15. Methods of detoxification and their role in treating patients with opioid dependence. O'Connor PG JAMA; 2005 Aug; 294(8):961-3. PubMed ID: 16118388 [No Abstract] [Full Text] [Related]
16. Retention in naltrexone implant treatment for opioid dependence. Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Hegstad S; Gossop M; Kristensen O; Waal H Drug Alcohol Depend; 2010 Sep; 111(1-2):166-9. PubMed ID: 20570059 [TBL] [Abstract][Full Text] [Related]